1628-26-R-RFIN-00005-V02

The Mississippi Division of Medicaid's Office of Procurement is seeking a Model Care Coordinator/Grant Manager through Request for Applications (RFA) #1628-26-R-RFIN-00005 to implement the Centers for Medicare and Medicaid Services Cell and Gene Therapy Access Model. The selected contractor will serve as a primary liaison supporting members receiving cell and gene therapies for sickle cell disease, with key responsibilities including care coordination, patient navigation, barriers screening, resource connection, and community outreach. Minimum qualifications require a Bachelor's Degree in Medical Sciences, Public Health, Social Work, or a related field, with preferred qualifications including a graduate degree and two years of healthcare access or patient navigation experience. The contract term spans approximately five years, commencing April 1, 2026, and concluding December 31, 2030, with the contractor working at the Mississippi Division of Medicaid's central office in Jackson. Application submissions, including resumes and three references, are due by February 6, 2026, at 2:00 p.m. CST, with questions accepted until January 26, 2026, at 2:00 p.m. CST.

The procurement is compensated at $50.48 per hour, not exceeding 1,840 hours annually, resulting in a total annual compensation of $92,883.20, with an additional 7.65% FICA employer's share of $7,105.56 and annual travel reimbursement up to $9,044, bringing maximum annual compensation to $109,032.76. The contract worker will be classified as an employee under IRS code, assigned a worker identification number, and receive a W-2 for tax purposes. Award of the contract is contingent upon approval by the Public Procurement Review Board and/or the Mississippi Department of Finance and Administration Office of Personal Service Contract Review. No specific set-aside designations or restrictions on responding organizations are mentioned in the procurement documents. The position is funded through the CGT Access Model Cooperative Agreement (CMS-2P2-25-001) and will be focused on supporting members through their cell and gene therapy treatment journeys, with an emphasis on patient education, care coordination, and resource connection.